MARKET

NUWE

NUWE

Nuwellis Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.590
-0.170
-4.52%
After Hours: 3.700 +0.11 +3.06% 17:48 05/18 EDT
OPEN
3.770
PREV CLOSE
3.760
HIGH
3.862
LOW
3.500
VOLUME
178.66K
TURNOVER
--
52 WEEK HIGH
37.50
52 WEEK LOW
3.424
MARKET CAP
23.45M
P/E (TTM)
-0.2037
1D
5D
1M
3M
1Y
5Y
ACC 2021 Presentation Adds to Body of Evidence Supporting Nuwellis Ultrafiltration to Treat Patients with Heart Failure
Treatment with Aquadex therapy showed significant weight decrease, clinical symptom improvement and decreased readmissions among heart failure patients.EDEN PRAIRIE, Minn., May 17, 2021 (GLOBE NEWSWIRE) -- Data supporting the effectiveness of Aquadex FlexF...
GlobeNewswire · 1d ago
Nuwellis Provides More Children in Texas With Access to Its Unique Fluid Management Technology
Gentle Ultrafiltration with Aquadex SmartFlow® Expands Options for Pediatric PatientsEDEN PRAIRIE, Minn., May 13, 2021 (GLOBE NEWSWIRE) -- Reaffirming its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric patie...
GlobeNewswire · 5d ago
Nuwellis, Inc. Announces 18 Percent Increase in Revenue for First Quarter 2021 Over Previous Year and Provides Company Update
GlobeNewswire · 05/11 13:00
Nuwellis EPS misses by $0.09, misses on revenue
Nuwellis (NUWE): Q1 GAAP EPS of -$1.25 misses by $0.09.Revenue of $1.9M (+16.6% Y/Y) misses by $0.18M.Shares -1.82% PM.Press Release
Seekingalpha · 05/11 12:49
BRIEF-Nuwellis Q1 Revenue Rose 18 Percent To $1.9 Million
reuters.com · 05/11 12:19
CHF Solutions Q1 EPS $(1.25) Down From $(0.37) YoY, Sales $1.92M Up From $1.63M YoY
CHF Solutions (NASDAQ:NUWE) reported quarterly losses of $(1.25) per share. This is a 237.84 percent decrease over losses of $(0.37) per share from the same period last year. The company reported $1.92 million in sales
Benzinga · 05/11 12:15
Nuwellis, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 11, 2021 / Nuwellis, Inc. (NASDAQ:NUWE) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 11, 2021 at 9:00 AM Eastern Time.
ACCESSWIRE · 05/11 12:15
Earnings Scheduled For May 11, 2021
  Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter.
Benzinga · 05/11 08:13
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NUWE. Analyze the recent business situations of Nuwellis Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NUWE stock price target is 17.13 with a high estimate of 22.25 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 26
Institutional Holdings: 1.46M
% Owned: 22.37%
Shares Outstanding: 6.53M
TypeInstitutionsShares
Increased
3
279.41K
New
7
890.95K
Decreased
0
0
Sold Out
2
1.19K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.31%
Healthcare Equipment & Supplies
+0.36%
Key Executives
Chairman/Director
John Erb
President/Chief Executive Officer/Chief Financial Officer
Nestor Jaramillo
Senior Vice President
Vitaliy Epshteyn
Chief Accounting Officer/Controller
Paul Wotta
Lead Director/Independent Director
Warren Watson
Independent Director
Steven Brandt
Independent Director
Maria Costanzo
Independent Director
Jon Salveson
Independent Director
Gregory Waller
No Data
  • All
  • Financials
  • Insiders
More
About NUWE
Nuwellis, Inc., formerly CHF Solutions, Inc., is a medical device company. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow system for ultrafiltration therapy that gently removes fluid and restores balance to patients suffering from fluid overload. The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System consists of three components: the console, which allows caregivers control of ultrafiltration therapy; the peripheral catheter draws blood from and returns blood to the patient, and the blood circuit set that filters the patient’s blood and collects excess water and salt. Its solutions also include RenalSense Clarity RMS, which is a kidney monitoring system that continuously measures urine output and flow, automatically displaying real-time data to the medical staff.

Webull offers kinds of Nuwellis Inc stock information, including NASDAQ:NUWE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUWE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NUWE stock methods without spending real money on the virtual paper trading platform.